Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.31 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.31 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | TSPO | P30536 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18020757 | 0.98 | L3MBTL1 (0.40) | RXRARXRBKDM4EATML3MBTL1 | |
| SCHEMBL18963044 | 0.98 | L3MBTL1 (0.40) | RXRARXRBKDM4EATML3MBTL1 | |
| SCHEMBL23370603 | 0.98 | RXRA (0.35) | RXRARXRBKDM4EATML3MBTL1 | |
| SCHEMBL24569000 | 0.98 | RXRA (0.38) | RXRARXRBKDM4EATML3MBTL1 | |
| SCHEMBL14212290 | 0.96 | ATM (0.40) | RXRARXRBKDM4EATML3MBTL1 | |
| SCHEMBL12865753 | 0.95 | KDM4E (0.34) | RXRARXRBKDM4EATML3MBTL1 | |
| SCHEMBL23370590 | 0.95 | TSPO (0.34) | RXRARXRBKDM4EATML3MBTL1 | |
| SCHEMBL23370513 | 0.95 | KDM4E (0.38) | RXRARXRBKDM4EATML3MBTL1 | |
| SCHEMBL16904391 | 0.95 | TSPO (0.34) | RXRARXRBKDM4EATML3MBTL1 | |
| SCHEMBL18963046 | 0.95 | KDM4E (0.38) | RXRARXRBKDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7883786-B2 | highly efficient and highly luminescent optical power and is superior in durability | CANON KABUSHIKI KAISHA (JP) | 2011-02-08 | — | — | US | disclosed |
| US-7883786-B2 | highly efficient and highly luminescent optical power and is superior in durability | CANON KABUSHIKI KAISHA (JP) | 2011-02-08 | — | — | US | disclosed |
| US-20080297034-A1 | BIPHENYL DERIVATIVE AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | CANON KABUSHIKI KAISHA (JP) | 2008-12-04 | — | — | US | disclosed |
| US-20080297034-A1 | BIPHENYL DERIVATIVE AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | CANON KABUSHIKI KAISHA (JP) | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080297034-A1 | BIPHENYL DERIVATIVE AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | LEF1, CYP1B1, ESR1 | RXRA 662/4885RXRB 632/4885KDM4E 585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.